Board Meetings for GLAXO
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 13 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 13 May 2026 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 09 Feb 2026 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 09 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 06 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 06 Nov 2025 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 01 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 01 Aug 2025 | Board Meeting Intimation | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 01-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 13 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 13 May 2025 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 14 Feb 2025 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 14 Feb 2025 | Financial Results | GLAXO : 14-Feb-2025 : The Company has informed the Exchange that a Board meeting to be held on February 10, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 14, 2025, To consider and approve the financial results for the period ended December 31, 2024 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 10 Feb 2025 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 10 Feb 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 29 Oct 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2024 and dividend |
Showing page 1 of 8 (107 total items)